Cambridge, MA Newmark has arranged the sale of 215 First St., 150 Second St. and 11 Hurley St., three life science assets. Newmark co-head of U.S. Capital Markets Robert Griffin and Boston Capital Markets executive vice chairman Edward Maher, vice chairman Matthew Pullen, executive managing director James Tribble, senior managing director Samantha Hallowell and associate director William Sleeper represented the undisclosed seller and procured the undisclosed buyer.

Totaling 552,543 s/f, the three assets offer a mix of in-place cash flow and upside potential.

“215 First St., 150 Second St. and 11 Hurley St. check all of the boxes for modern life science users,” said Sleeper. “Each asset offers laboratory-ready infrastructure and high-quality interior buildouts that are conducive to a variety of tenant requirements.”

The three assets are located in the city’s Kendall Sq. submarket, within walking distance of diverse amenities, blue-chip employers, the MIT campus and an MBTA Red Line station connecting to Downtown Boston.

Newmark financial analyst Grady Zink provided financial analysis support for the transaction.